Press-release for stocks

Prices are updated after-hours

crawled time : 16:20

save search

ChemoCentryx Reports First Quarter 2022 Financial Results and Recent Highlights
Published: 2022-05-05 (Crawled : 16:20) - ir.chemocentryx.com
CCXI | News | $51.99 -0.04%

Health Technology

| 232.42% | O: 16.75% H: 0.0% C: 0.0%
results

Vaccinex Announces $6.6 Million Private Placement
Published: 2022-01-27 (Crawled : 16:20) - ir.vaccinex.com
VCNX | $4.9631 -2.76% 3.5K

Health Technology

| 442.08% | O: 14.75% H: 8.57% C: 7.62%
ces vaccine

Cyclerion Therapeutics to Present Clinical Trial Design for CY6463 Phase 2a Study in Participants with Alzheimer’s Disease with Vascular Pathology at the Alzheimer’s Association International Conference 2021 (AAIC)
Published: 2021-07-22 (Crawled : 16:20) - ir.cyclerion.com
CYCN | $3.05 -12.54% 720

Health Technology

| -15.28% | O: 14.44% H: 0.0% C: 0.0%
disease alzheimer phase 2 trial conference cy6463 alzheimer’s alzheimer's disease alzheimer's designation phase 2b

Jaguar Animal Health to Host Treatment Forum for Veterinarians About Chemotherapy-Induced Diarrhea (CID) in Dogs on Sunday, January 16th During the Veterinary Meeting & Expo (VMX) Conference in Orlando, Florida
Published: 2022-01-12 (Crawled : 16:20) - jaguarhealth.gcs-web.com
FNCTF | News | $11.16 -20.84% 130

Communications

| 1.73% | O: 0.0% H: 0.0% C: 0.0%
JAGX | News | $0.1704 1.43% 1.41% 34M

Health Technology

| -81.72% | O: 12.9% H: 0.0% C: 0.0%
veterinarians treatment health conference diarrhea therapy

Cyclerion Announces CY6463 Clinical Pipeline Progress and First Quarter 2022 Financial Results
Published: 2022-05-04 (Crawled : 16:20) - ir.cyclerion.com
CYCN | $3.05 -12.54% 720

Health Technology

| 306.67% | O: 11.24% H: 0.0% C: -14.95%
cy6463 results

Atea Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
Published: 2022-02-28 (Crawled : 16:20) - ir.ateapharma.com
AVIR | $3.705 -0.67% -0.67% 200K

Health Technology

| -41.17% | O: 10.41% H: 4.57% C: -7.71%
als financial results report results

Sypris Wins Electronic Warfare Program
Published: 2022-02-01 (Crawled : 16:20) - ir.sypris.com
SYPR 4 | $1.39 -9.15% -10.07% 34K

Producer Manufacturing

| -24.26% | O: 7.92% H: 5.5% C: 1.38%
program

Sypris Reports Fourth Quarter Results
Published: 2022-03-17 (Crawled : 16:20) - ir.sypris.com
SYPR 4 | $1.39 -9.15% -10.07% 34K

Producer Manufacturing

| -34.62% | O: 7.26% H: 2.78% C: -0.8%
report results

UPDATE -- Helius Medical Technologies, Inc. Announces Publication of its PoNS™ Registrational Clinical Trial (TBI-001) in TBI
Published: 2020-04-30 (Crawled : 16:20) - globenewswire.com
HSDT | $4.82 -3.21% -3.32% 17K

Health Technology

| 1132.67% | O: 6.93% H: 7.64% C: -0.72%
trial pons

Jaguar Health Announces the Presentation of Findings from the Investigator-Initiated Phase 2 HALT-D Study of Crofelemer for Prevention of Chemotherapy-Induced Diarrhea (CID) in Breast Cancer Patients at San Antonio Breast Cancer Symposium (SABCS 2021)
Published: 2021-12-10 (Crawled : 16:20) - jaguarhealth.gcs-web.com
JAGX | News | $0.1704 1.43% 1.41% 34M

Health Technology

| -87.31% | O: 5.22% H: 0.0% C: 0.0%
health phase 2 symposium sabcs presentation diarrhea therapy cancer breast cancer initiated crofelemer

AVEO Oncology Presents Three Posters for Tivozanib/Immunotherapy Combinations at the 2022 ASCO GI Cancers Symposium
Published: 2022-01-20 (Crawled : 16:20) - investor.aveooncology.com
AVEO | $15.0 0.0% 0

Health Technology

| 302.01% | O: 4.69% H: 0.0% C: -7.81%
symposium immunotherapy asco therapy cancer

Radius Adds Industry Veterans Jennifer A. Jarrett and Susan Vissers Lisa to Board of Directors
Published: 2022-05-20 (Crawled : 16:20) - ir.radiuspharm.com
CSGKF | $0.89 4.69% 51K

Finance

| -86.76% | O: 1.93% H: 0.0% C: -1.46%
CVS | $67.77 -1.07% -0.06% 8.6M

Retail Trade

| -26.45% | O: 0.11% H: 0.0% C: 0.0%
CS | $0.8858 1.49% 64M

Finance

| -86.88% | O: 1.41% H: 0.0% C: 0.0%
C | $62.47 -0.32% -0.18% 10M

Finance

| 25.89% | O: 0.96% H: 0.0% C: 0.0%
BSX | $72.91 5.68% -0.03% 15M

Health Technology

| 74.7% | O: -0.2% H: 0.0% C: 0.0%
RDUS | $17.9 1.47% 1.45% 320K

Health Technology

| 194.49% | O: -2.67% H: 0.0% C: 0.0%
COWN | $38.99 0.31% 0.0% 0

Finance

| 68.44% | O: 4.67% H: 0.0% C: 0.0%

Trump’s SPAC soars in stock market before merger with Truth Social – EL PAÍS USA
Published: 2024-02-16 (Crawled : 16:20) - spacfeed.com
VRSSF | $0.7272 -0.66% 120K

n/a

| -33.64% | O: 0.0% H: 7.27% C: 4.55%
VS | $1.39 2.21% 2.16% 14K

Information

| -34.3% | O: 4.14% H: 5.07% C: 2.98%
spac usa market

Cyclerion Announces CY6463 Clinical Pipeline and Corporate Updates
Published: 2022-02-24 (Crawled : 16:20) - ir.cyclerion.com
LLY | News | $732.2 -1.81% 0.18% 2.1M

Health Technology

| 214.52% | O: 3.94% H: 0.0% C: 0.0%
CYCN | $3.05 -12.54% 720

Health Technology

| 206.22% | O: 0.4% H: 3.0% C: -3.87%
cy6463 ces

Sypris Wins Long-Term, Sole-Source Contract Extension to Supply Drivetrain Components for Commercial Vehicles
Published: 2022-03-08 (Crawled : 16:20) - ir.sypris.com
SYPR 4 | $1.39 -9.15% -10.07% 34K

Producer Manufacturing

| -53.35% | O: 3.66% H: 2.94% C: -22.35%
contract vehicles one commercialization

Radius Health, Inc. Fourth Quarter & Full Year 2021 Results
Published: 2022-02-24 (Crawled : 16:20) - ir.radiuspharm.com
FNCTF | News | $11.16 -20.84% 130

Communications

| -10.0% | O: -2.2% H: 0.0% C: -0.14%
RDUS | $17.9 1.47% 1.45% 320K

Health Technology

| 154.91% | O: 3.32% H: 14.41% C: 13.99%
health results

Jaguar Animal Health to Host Treatment Forum for Veterinarians About Chemotherapy-Induced Diarrhea (CID) in Dogs on Sunday, March 6th, During the Western Veterinary Conference (WVC) in Las Vegas
Published: 2022-03-01 (Crawled : 16:20) - jaguarhealth.gcs-web.com
JAGX | News | $0.1704 1.43% 1.41% 34M

Health Technology

| -62.68% | O: 2.72% H: 10.71% C: 0.45%
veterinarians day treatment health conference diarrhea therapy

ChemoCentryx to Participate in Two Upcoming Investor Conferences
Published: 2021-11-10 (Crawled : 16:20) - ir.chemocentryx.com
CCXI | News | $51.99 -0.04%

Health Technology

| 36.74% | O: 2.6% H: 7.01% C: -2.61%
conference